![Axial T2W MRI image shows absence of septum pellucidum.](/sites/default/files/styles/figure_image_teaser_large/public/figure_image/2024-05/FIGURE%201_small.png?itok=DFwzbCVU)
Neuroradiology
Case TypeCase Series
Authors
Ioana-Andreea Cirlig 1,2, Lucian-Mihai Florescu 1,3, Denisa-Maria Zavelca 1, Cristina-Mihaela Ciofiac 1,2, Ioana-Andreea Gheonea 1,3
Patient48 years, female & 56 years, female
The second patient, a 48-year-old woman, was diagnosed with cervical cancer and was recommended to undergo a CT scan for neoplastic staging. In childhood, she was diagnosed with anophthalmia and subsequently fitted with an ocular prosthesis in her right eye. She has hyperopia and presbyopia in the left eye.
Neither patient has had other skull imaging yet.
The brain MRI examination revealed enlarged lateral ventricles with pointing down frontal horns on coronal images and absent septum pellucidum, alongside a thinned-out corpus callosum. The pituitary gland exhibits reduced dimensions. Unilateral hypoplastic optic nerve and globe is also seen on the right side.
At the contrast-enhanced CT scan of the head, enlargement of the lateral ventricles with absence of the septum pellucidum was also highlighted, along with a “point down” appearance of the lateral ventricular frontal horns on coronal images, together with a hypoplastic right optic nerve and eyeball. Additionally, the ocular prosthesis is also observed.
Background
Septo-optic dysplasia (SOD), also known as de Morsier syndrome, is a rare congenital malformation syndrome with an estimated prevalence of ~1:10,000, having no gender predilection recognition. SOD is a result of abnormalities in the embryonic forebrain development occurring between 4 to 6 weeks of pregnancy, involving both genetic and environmental factors [1]. The syndrome is characterised by uni or bilateral optic nerve hypoplasia, hypothalamic-pituitary dysfunction and midline brain defects such as the absence of the septum pellucidum and/or thinning or agenesis of the corpus callosum. For a diagnosis to be made, at least two of these characteristics must be present [2,3].
Clinical Perspective
Some individuals present with SOD at birth, while others may manifest symptoms characterised by growth failure and/or visual abnormalities during childhood [4]. The manifestations of SOD can be categorised into symptoms associated with underdevelopment of the optic nerve (visual impairment in one or both eyes), abnormalities in pituitary hormone function (growth hormone deficiency and other endocrine dysfunctions), and anomalies in midline brain structures (neurological problems such as seizures, developmental delay or intellectual disability) [5]. The clinical presentation also depends on whether there is an association with schizencephaly (in approximately 50% of cases). This association, known as septo-optic dysplasia plus, is characterised by a less severe impairment of the optic apparatus and cortical anomalies (polymicrogyria and cortical dysplasia) [6,7].
Imaging Perspective
Imaging plays a critical role in diagnosing SOD. A CT scan may reveal the absence of the septum pellucidum, enlarged ventricles and hypoplastic optic nerve/globe. MRI is the preferred imaging method because, in addition to CT, it can better characterise the optic pathway, but it can also provide information about potential anomalies of the corpus callosum (hypoplasia/agenesis), pituitary gland (small pituitary gland with hypoplastic or absent infundibulum and ectopic posterior pituitary seen as a focus of T1 high signal intensity in the median eminence of the hypothalamus), and can highlight the absence of olfactory bulbs (arhinencephaly). The MRI findings eliminate the necessity for additional investigations to confirm the diagnosis [8].
Outcome
The clinical examination is more than important, but the complete diagnosis cannot be formulated without an MRI examination. The impact of imaging is evident, as it is essential for the patient to be treated appropriately. Symptomatic treatment for SOD requires oversight by a multidisciplinary team and ongoing monitoring. The prognosis varies depending on the severity of the condition. Early diagnosis significantly improves outcomes by facilitating the timely management of hormone deficiencies.
Take Home Message / Teaching Points
Radiologist awareness and recognition of characteristic features of SOD on MRI imaging, are crucial for accurate diagnosis and proper management of these patients.
[1] Webb EA, Dattani MT (2010) Septo-optic dysplasia. Eur J Hum Genet 18(4):393-7. doi: 10.1038/ejhg.2009.125. (PMID: 19623216)
[2] Sataite I, Cudlip S, Jayamohan J, Ganau M (2021) Septo-optic dysplasia. Handb Clin Neurol 181:51-64. doi: 10.1016/B978-0-12-820683-6.00005-1. (PMID: 34238479)
[3] Mann A, Aghababaie A, Kalitsi J, Martins D, Paloyelis Y, Kapoor RR (2023) Neurodevelopmental impairments in children with septo-optic dysplasia spectrum conditions: a systematic review. Mol Autism 14(1):26. doi: 10.1186/s13229-023-00559-0. (PMID: 37491272)
[4] Al-Salihi MM, Qassim T, Aji N, Al-Jebur MS, Rahman MM, Ayyad A (2023) The clinical aspects of septo-optic dysplasia: A narrative review with illustrative case report. Int J Surg Case Rep 109:108575. doi: 10.1016/j.ijscr.2023.108575. (PMID: 37524018)
[5] Ferran Kd, Paiva IA, Gilban DL, Resende M, Souza MA, Beserra IC, Guimarães MM (2010) Septo-optic dysplasia. Arq Neuropsiquiatr 68(3):400-5. doi: 10.1590/s0004-282x2010000300014. (PMID: 20602044)
[6] Zoric L, Nikolic S, Stojcic M, Zoric D, Jakovljevic S (2014) Septo-optic dysplasia plus: a case report. BMC Res Notes 7:191. doi: 10.1186/1756-0500-7-191. (PMID: 24678945)
[7] Singh G, Sharma R, Hartung M, et al (Updated 21 Feb 2024) Septo-optic dysplasia. In: Radiopaedia.org [Internet]. Accessed on 31 May 2024. https://doi.org/10.53347/rID-4800
[8] Maurya VK, Ravikumar R, Bhatia M, Rai R (2015) Septo-optic dysplasia: Magnetic Resonance Imaging findings. Med J Armed Forces India 71(3):287-9. doi: 10.1016/j.mjafi.2015.04.013. (PMID: 26286097)
URL: | https://eurorad.org/case/18571 |
DOI: | 10.35100/eurorad/case.18571 |
ISSN: | 1563-4086 |
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.